Researched and fact-checked in-house against primary literature and regulator records. Not reviewed by a named clinician — how we work.
Evidence-rated reference Updated August 2026
We sell nothing. No vendor sponsorship. Editorial policy
pepteyes .com
Research Use Only Longevity & Mitochondrial Evidence 2/5 · Limited

Epitalon

Also known as Epithalon · AEDG peptide · Ala-Glu-Asp-Gly

Synthetic tetrapeptide modelled on the pineal extract epithalamin

Overview

The flagship "longevity peptide", built on decades of work by a single Russian research group reporting telomerase activation and reduced mortality. The claims are extraordinary; the independent replication is absent.

Not approved for human use anywhereNo approval anywhere for human use. Sold under research-use labelling. Not approved for human use in the US, EU or UK.

At a glance
Regulatory statusNot approved in the US, EU or UK. Used in Russian gerontology practice. Widely sold as an anti-aging research peptide.
Drug classSynthetic tetrapeptide modelled on the pineal extract epithalamin
RouteSubcutaneous or intranasal (research)
Half-lifeVery short — minutes
Evidence rating
2/5 Limited Evidence rating 2 out of 5: Limited
Preclinical work plus scattered human reports, uncontrolled use, or negative trials.
Studied inRussian studies in elderly cohorts reporting reduced mortality over multi-year follow-up; cell culture telomerase work; rodent lifespan studies.

How it works

Proposed to induce telomerase reverse transcriptase expression, lengthening telomeres in cultured cells, and to normalise pineal melatonin rhythm and neuroendocrine function. Some work suggests direct interaction with promoter regions of specific genes.

Evidence base

Rated 2 of 5 — Limited. Preclinical work plus scattered human reports, uncontrolled use, or negative trials.

  • Single-group evidence base with high-stakes unreplicated claims.

Benefits & potential uses

Bars indicate how well each claim is supported: three = strong human evidence, two = moderate, one = preliminary or preclinical.

  • Telomerase activation in cell culture Preliminary

    Reported induction of telomerase and telomere elongation in human somatic cell cultures — the core scientific claim.

  • Melatonin rhythm normalisation Preliminary

    Studies report restored nocturnal melatonin secretion in older subjects, with corresponding sleep improvements.

  • Reduced mortality in Russian cohort studies Preliminary

    Long-term follow-up studies reported lower mortality in treated elderly groups. Methodology and independence are significant caveats.

  • Antioxidant effects in animal models Preliminary

    Reduced lipid peroxidation and improved antioxidant enzyme activity in rodents.

Risks, cons & cautions

Bars indicate seriousness: three = serious or common, two = moderate, one = minor.

  • No independent replication Serious

    Nearly all supporting work traces to one research group. Extraordinary claims with a single source are not established findings.

  • Telomerase activation and cancer Serious

    Telomerase reactivation is a hallmark of most cancers. A drug designed to switch it on systemically has an obvious and unstudied oncologic concern.

  • No Western trials Serious

    No FDA or EMA review; no registered trials with contemporary methodology.

  • Unregulated supply Serious

    Sold as a research chemical with no purity assurance.

  • No established safe dosing Moderate evidence

    Protocols circulating online have no clinical validation.

Who should avoid it

  • Any cancer history or active malignancy
  • Pregnancy
  • Anyone unwilling to accept entirely unquantified long-term risk

If used under medical supervision, monitor

  • No validated monitoring; age-appropriate cancer screening is prudent for anyone considering it

Commonly confused with

These mix-ups cause real harm — two products sold under one name, or two molecules whose effects run in opposite directions.

Thymalin Limited Approval Evidence 2/5

Both come from the same Russian gerontology research tradition and are sold together as an anti-aging pair. Neither has independent replication outside that tradition.

Compare side by side

Not approved for human use in the US, EU or UK.

Infographic

Epitalon — benefits & risks at a glance Download SVG
Infographic summarising the benefits and risks of Epitalon, from pepteyes.com

Where to read further

We link to live literature searches rather than a frozen citation list, so you always see current results — including anything published after our last review.

longevitytelomerasepinealresearch chemicalunreplicated

Related peptides in Longevity & Mitochondrial

Terms used on this page

Reproducibility and Replication
Reproducibility is obtaining the same result from the same data and analysis, while replication is obtaining a consistent result from new data, and only the second shows the finding is real.
Research Chemical Market
The research chemical market is the trade in compounds sold as laboratory reagents under research-use disclaimers, in practice supplying individuals with substances that have no approved human use.

This page is educational information, not medical advice. It cannot account for your medical history, medications, or risk factors. Do not start, stop or change any treatment based on it. Speak to a qualified healthcare professional who knows your case.